Men with high prolactin levels often see improved libido and sexual function with the safe use of cabergoline under the guidance of an endocrinology specialist. This is because Cabergoline for Bodybuilding normalizes serum prolactin, boosting testosterone and other endocrine hormones.
However, it is important to tell your doctor about any medications, vitamins or herbal supplements you are taking, as some may interact with this medication.
Testosterone
Testosterone is a hormone in males and females that regulates secondary sexual characteristics, such as a deeper voice and facial hair, and helps to increase muscle mass. It also helps to stimulate erythropoiesis, which results in a higher hematocrit in males compared to females. It is also known to help maintain normal brain function and a healthy mood.
The brain signals the pituitary gland to produce testosterone in response to certain chemicals and hormones that circulate in the bloodstream. The pituitary gland then sends this information to the testicles, where the hormone is secreted into the bloodstream to reach other tissues in the body.
In males, the hormone helps to regulate sperm production and promotes erectile tissue growth. It is also essential for male reproductive health, and plays a role in sex drive and sexual desire. Testosterone levels naturally decline with age in both males and females, though they tend to decrease faster for men than for women.
When the body’s natural supply of testosterone drops too low, symptoms can develop that include a loss of libido and infertility. In addition, some physical changes can occur, including reduced bone density and muscle mass and a change in body hair and nipple discharge. In some cases, low testosterone can contribute to depression and other emotional problems.
One of the reasons that testosterone is important during fetal development is because it is necessary to trigger male characteristics, such as masculine breast growth and the closure of the epiphyseal plate during puberty. A testosterone deficiency during fetal development can cause androgen insensitivity syndrome (AIS) which occurs when a person is genetically male, but is insensitive to androgens and cannot grow or develop normally.
A study examining 51 patients with hyperprolactinemia due to a micro- or macroprolactinoma found that six months of treatment with cabergoline restored testosterone levels and restored sexual potency in most men. In addition, the drug normalized prolactin levels and improved gonadal function more rapidly than did bromocriptine. This suggests that cabergoline is a more effective therapy for AIS than bromocriptine. It is possible that the higher level of testosterone may also improve sexual function in some patients with delayed ejaculation, but further research is needed to confirm this.
Prolactin
Prolactin is a hormone secreted by the pituitary gland in the brain. In men, elevated prolactin results in decreased testosterone and erectile dysfunction. Cabergoline inhibits the production of prolactin and increases testosterone, arousal, and sexual function. In addition, cabergoline is effective in treating other conditions related to low testosterone levels such as oligoathenospermia and reduced motility in males.
Cabergoline also normalizes prolactin levels and improves gonadal function in hyperprolactinemic males with large macroprolactinomas. Compared to bromocriptine, cabergoline has greater efficacy in improving sexual desire and function in men with prolactinomas and improves the quality of sexual intercourse.
In a clinical study, serum prolactin and testosterone concentrations were measured before and after 6 months of treatment with cabergoline. The study also included seminal fluid analysis, functional seminal tests, and cerebrum magnetic resonance imaging. The study found that all patients had a history of prolactin-secreting macroadenomas. All of the patients had low sperm counts with oligoasthenospermia, poor motility and erectile function. The patients had high rates of sexual dissatisfaction.
The study found that testosterone levels were higher after cabergoline treatment than before, but the rate of improvement was not as great for prolactin levels. Univariate and multivariate analyses showed that response to cabergoline was associated with duration of treatment and being on testosterone therapy. Other factors such as age, hormone levels before and after cabergoline, history of prostatectomy, psychotropic drug use other than cabergoline, and prostate volume were not associated with response to the treatment.
To investigate whether the effect of cabergoline on arousal and sexual function was mediated by a feedback mechanism, participants were given an intravenous injection of protirelin (one-eighth to one-quarter the dose used diagnostically in the thyrotropin releasing hormone test). Plasma samples were collected at each time point: sample 0 represented a basal value prior to i.v. administration, sample 1 depicted a neutral stimulus-induced response, sample 2 depicted a film-induced sexual arousal, and sample 3 demonstrated the reaction to orgasm. The researchers found that coadministration of protirelin completely abrogated the arousal and sexual enhancements observed under single cabergoline administration. The authors concluded that the dopamine agonist properties of cabergoline may account for its effects on sexual behavior, but the inhibition of prolactin secretion is not sufficient to induce these effects.
Libido
The sex drive is a complex phenomenon with a variety of factors that can influence it. Men and women have different biological drives that can cause them to be more or less interested in sexual activity, depending on sex hormone levels. However, libido can also be influenced by psychological factors such as stress, depression, and low self-esteem. Additionally, certain diseases such as diabetes or HIV may have a negative impact on the libido.
Whether someone has high or low sex drive, there are a variety of ways they can address the issue. A doctor can perform tests to assess the cause and recommend hormonal replacement therapy, behavioral therapy, or medications. Medications such as anti-depressants, blood pressure drugs, and recreational drugs can all impact libido, so it’s important to disclose any and all medications and supplements you’re taking to your doctor.
Researchers have found that cabergoline is able to increase sexual desire and orgasm in men with hyperprolactinemia by lowering prolactin levels. To determine the effects of cabergoline on prolactin and the sexual response, researchers performed a single-blind, placebo-controlled trial in ten healthy men. During this study, sex drive was evaluated using an erotic film and masturbation, and the quality and intensity of the orgasm was recorded. Plasma levels of prolactin were pharmacologically increased to high concentrations (protirelin, 50 ug iv) or decreased to physiological levels (cabergoline, 0*5 mg p.o). Both arousal and orgasm were significantly enhanced with cabergoline administration compared to control. In addition, co-administration of protirelin abolished the libido and orgasm increases observed with cabergoline administration.
The authors of this study found that libido was reduced in 70% of macroprolactinomas and 50% of microprolactinomas, but after 6 months of treatment with cabergoline, serum testosterone normalised in all patients. They concluded that post-orgasmic changes in prolactin probably do not represent a direct negative feedback to the CNS, but rather that these are one signal among many neuropeptides and monoamines that control sexual response. They further suggested that a combination of prolactin and testosterone modulates sexual motivation and behavior. This study was published in the Journal of Clinical Endocrinology and Metabolism.
Read More Blog: Cabergoline How to Buy the Right Dose at the Best Price
Orgasm
Men with delayed orgasm or anorgasmia have few treatment options, but cabergoline may improve these conditions. The authors of this study retrospectively reviewed medical records of patients treated at a single andrology clinic for hyperprolactinemia and then evaluated their response to cabergoline therapy, defined as improvement in or return of normal orgasm. They also compared these men with patients who did not respond to cabergoline therapy. The authors excluded men with prostate cancer, those who received cabergoline for other conditions unrelated to orgasm, and those receiving concomitant testosterone replacement therapy. They found that 69% of the men improved or returned to normal orgasm. Interestingly, the length of cabergoline therapy and whether patients were on testosterone therapy increased the likelihood of improvement in orgasm. However, these factors did not completely explain the results.
The authors suggest that the enhancing effect of cabergoline is not related to its direct prolactin inhibitory action on pituitary cells, but rather to the indirect dopamine-related stimulation of orgasm-related brain areas. Their hypothesis is supported by the fact that pharmacologically increasing prolactin levels with the prolactin receptor antagonist protirelin completely abolished the sexual increases observed with cabergoline administration, suggesting that the enhancing effect of cabergoline on orgasm and sexual desire is not exclusively due to its direct effects on prolactin.
In their research, the authors performed a placebo-controlled, cross-over experiment in ten healthy males. The participants watched an erotic film while endocrine and neuroendocrine parameters were measured. Plasma prolactin and follicle stimulating hormone (FSH) and luteinizing hormone (LH) levels were increased in one group and reduced in the other, while testosterone and pheromones were unaffected. The researchers found that the quality and intensity of orgasm increased significantly with cabergoline, but not in the placebo group.
The authors conclude that cabergoline is an effective and easy-to-administer treatment for patients with orgasm and anorgasmia, regardless of age or etiology. They recommend that it be considered in addition to other treatments for psychogenic erectile dysfunction. This is a very common condition caused by psychological and behavioral factors and can have many causes, such as low self-esteem, anxiety, and depression.